dihydroxyphenylalanine has been researched along with Hypercalcemia in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Hypercalcemia: Abnormally high level of calcium in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Woert, MH | 1 |
| Weintraub, MI | 1 |
| Dahlström, A | 1 |
| Ericson, LE | 1 |
2 other studies available for dihydroxyphenylalanine and Hypercalcemia
| Article | Year |
|---|---|
Predicting the response to levodopa.
Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dih | 1971 |
Monoamines in rat thyroid parafollicular cells and the effect of vitamin D 2 -induced degranulation.
Topics: 5-Hydroxytryptophan; Amines; Animals; Calcitonin; Calcium; Cytoplasmic Granules; Dihydroxyphenylalan | 1972 |